Literature DB >> 17172462

X-linked retinoschisis: an update.

Stephen K Sikkink1, Susmito Biswas, Neil R A Parry, Paulo E Stanga, Dorothy Trump.   

Abstract

X-linked retinoschisis is the leading cause of macular degeneration in males and leads to splitting within the inner retinal layers leading to visual deterioration. Many missense and protein truncating mutations have now been identified in the causative retinoschisis gene (RS1) which encodes a 224 amino acid secretory retinal protein, retinoschisin. Retinoschisin octamerisation is implicated in cell-cell interactions and cell adhesion perhaps by interacting with beta2 laminin. Mutations cause loss of retinoschisin function by one of the three mechanisms: by interfering with protein secretion, by preventing its octamerisation or by reducing function in the secreted octamerised protein. The development of retinoschisis mouse models have provided a model system that closely resembles the human disease. Recent reports of RS1 gene transfer to these models and the sustained restoration of some retinal function and morphology suggest gene replacement may be a possible future therapy for patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17172462      PMCID: PMC2598044          DOI: 10.1136/jmg.2006.047340

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  77 in total

1.  X-linked congenital retinoschisis.

Authors:  U Kellner; S Brümmer; M H Foerster; A Wessing
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

2.  Molecular pathology of X linked retinoschisis: mutations interfere with retinoschisin secretion and oligomerisation.

Authors:  T Wang; A Zhou; C T Waters; E O'Connor; R J Read; D Trump
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

3.  Assessment of RS1 in X-linked juvenile retinoschisis and sporadic senile retinoschisis.

Authors:  A Gehrig; K White; B Lorenz; M Andrassi; S Clemens; B H Weber
Journal:  Clin Genet       Date:  1999-06       Impact factor: 4.438

4.  Familial foveal retinoschisis.

Authors:  R A Lewis; G B Lee; C L Martonyi; J M Barnett; H F Falls
Journal:  Arch Ophthalmol       Date:  1977-07

5.  Visual acuity in 183 cases of X-chromosomal retinoschisis.

Authors:  H Forsius; U Krause; J Helve; V Vuopala; E Mustonen; B Vainio-Mattila; J Fellman; A W Eriksson
Journal:  Can J Ophthalmol       Date:  1973-07       Impact factor: 1.882

6.  Foveal retinoschisis and retinal detachment in severely myopic eyes with posterior staphyloma.

Authors:  M Takano; S Kishi
Journal:  Am J Ophthalmol       Date:  1999-10       Impact factor: 5.258

7.  Three widespread founder mutations contribute to high incidence of X-linked juvenile retinoschisis in Finland.

Authors:  L Huopaniemi; A Rantala; H Forsius; M Somer; A de la Chapelle; T Alitalo
Journal:  Eur J Hum Genet       Date:  1999-04       Impact factor: 4.246

8.  Clinical characteristics of 14 japanese patients with X-linked juvenile retinoschisis associated with XLRS1 mutation.

Authors:  K Shinoda; S Ishida; Y Oguchi; Y Mashima
Journal:  Ophthalmic Genet       Date:  2000-09       Impact factor: 1.803

9.  Correlation of optical coherence tomography findings with visual acuity and macular lesions in patients with X-linked retinoschisis.

Authors:  Marsha A Apushkin; Gerald A Fishman; Mark J Janowicz
Journal:  Ophthalmology       Date:  2005-03       Impact factor: 12.079

10.  OCT images and surgery of juvenile Macular retinoschisis.

Authors:  C Azzolini; L Pierro; M Codenotti; R Brancato
Journal:  Eur J Ophthalmol       Date:  1997 Apr-Jun       Impact factor: 1.922

View more
  59 in total

Review 1.  AAV-mediated gene therapy in mouse models of recessive retinal degeneration.

Authors:  J-J Pang; L Lei; X Dai; W Shi; X Liu; A Dinculescu; J H McDowell
Journal:  Curr Mol Med       Date:  2012-03       Impact factor: 2.222

Review 2.  The Transduction Cascade in Retinal ON-Bipolar Cells: Signal Processing and Disease.

Authors:  Kirill A Martemyanov; Alapakkam P Sampath
Journal:  Annu Rev Vis Sci       Date:  2017-07-17       Impact factor: 6.422

3.  Circadian regulation of retinoschisin in the chick retina.

Authors:  Michael L Ko; Yilin Liu; Liheng Shi; Dorothy Trump; Gladys Y-P Ko
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

4.  Clinical observations of vitreoretinal surgery for four different phenotypes of X-linked congenital retinoschisis.

Authors:  Chen Zhao; Qi Zhang; Hai-Ying Jin; Pei-Quan Zhao
Journal:  Int J Ophthalmol       Date:  2018-06-18       Impact factor: 1.779

5.  Retinoschisin (RS1) interacts with negatively charged lipid bilayers in the presence of Ca2+: an atomic force microscopy study.

Authors:  Svetlana Kotova; Camasamudram Vijayasarathy; Emilios K Dimitriadis; Laertis Ikonomou; Howard Jaffe; Paul A Sieving
Journal:  Biochemistry       Date:  2010-08-24       Impact factor: 3.162

6.  Macular hole in juvenile X-linked retinoschisis.

Authors:  Nayef Al-Swaina; Sawsan R Nowilaty
Journal:  Saudi J Ophthalmol       Date:  2013-05-30

7.  Lamellar macular hole in X linked retinoschisis.

Authors:  Vinod Kumar; Neha Goel
Journal:  BMJ Case Rep       Date:  2016-05-11

8.  Mutations in the RS1 gene in a Chinese family with X-linked juvenile retinoschisis.

Authors:  Qiaofang Hou; Yan Chu; Qiannan Guo; Dong Wu; Shixiu Liao
Journal:  Intractable Rare Dis Res       Date:  2012-02

9.  Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin.

Authors:  Guo-Jie Ye; Ewa Budzynski; Peter Sonnentag; Paul E Miller; Alok K Sharma; James N Ver Hoeve; Kellie Howard; David R Knop; Martha Neuringer; Trevor McGill; Jonathan Stoddard; Jeffrey D Chulay
Journal:  Hum Gene Ther Clin Dev       Date:  2015-09       Impact factor: 5.032

10.  The effects of transient retinal detachment on cavity size and glial and neural remodeling in a mouse model of X-linked retinoschisis.

Authors:  Gabriel Luna; Sten Kjellstrom; Mark R Verardo; Geoffrey P Lewis; Jiyun Byun; Paul A Sieving; Steven K Fisher
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-04-22       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.